These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 8290266

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Increased prevalence of K-ras oncogene mutations in lung adenocarcinoma.
    Mills NE, Fishman CL, Rom WN, Dubin N, Jacobson DR.
    Cancer Res; 1995 Apr 01; 55(7):1444-7. PubMed ID: 7882350
    [Abstract] [Full Text] [Related]

  • 4. Quantitative enriched PCR (QEPCR), a highly sensitive method for detection of K-ras oncogene mutation.
    Ronai Z, Minamoto T.
    Hum Mutat; 1997 Apr 01; 10(4):322-5. PubMed ID: 9338587
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Parental exposure to medications and hydrocarbons and ras mutations in children with acute lymphoblastic leukemia: a report from the Children's Oncology Group.
    Shu XO, Perentesis JP, Wen W, Buckley JD, Boyle E, Ross JA, Robison LL, Children's Oncology Group.
    Cancer Epidemiol Biomarkers Prev; 2004 Jul 01; 13(7):1230-5. PubMed ID: 15247135
    [Abstract] [Full Text] [Related]

  • 8. Rapid and sensitive nonradioactive detection of mutant K-ras genes via 'enriched' PCR amplification.
    Kahn SM, Jiang W, Culbertson TA, Weinstein IB, Williams GM, Tomita N, Ronai Z.
    Oncogene; 1991 Jun 01; 6(6):1079-83. PubMed ID: 1676837
    [Abstract] [Full Text] [Related]

  • 9. Detection of infrequent and multiple K-ras mutations in human tumors and tumor-adjacent tissues.
    Keohavong P, Zhu D, Whiteside TL, Swalsky P, Bakker A, Elder EM, Siegfried JM, Srivastava S, Finkelstein SD.
    Anal Biochem; 1997 May 01; 247(2):394-403. PubMed ID: 9177704
    [Abstract] [Full Text] [Related]

  • 10. K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization.
    Hruban RH, van Mansfeld AD, Offerhaus GJ, van Weering DH, Allison DC, Goodman SN, Kensler TW, Bose KK, Cameron JL, Bos JL.
    Am J Pathol; 1993 Aug 01; 143(2):545-54. PubMed ID: 8342602
    [Abstract] [Full Text] [Related]

  • 11. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
    Hsieh JS, Lin SR, Chang MY, Chen FM, Lu CY, Huang TJ, Huang YS, Huang CJ, Wang JY.
    Am Surg; 2005 Apr 01; 71(4):336-43. PubMed ID: 15943410
    [Abstract] [Full Text] [Related]

  • 12. Detection of K-ras point mutation by enriched PCR-colorimetric plate assay.
    Santiago FS, Todd AV, Hawkins NJ, Ward RL.
    Mol Cell Probes; 1997 Feb 01; 11(1):33-8. PubMed ID: 9076712
    [Abstract] [Full Text] [Related]

  • 13. Rapid detection of exon 1 NRAS gene mutations using universal heteroduplex generator technology.
    Belli C, De Brasi C, Larripa I.
    Hum Mutat; 2003 Feb 01; 21(2):132-7. PubMed ID: 12552560
    [Abstract] [Full Text] [Related]

  • 14. Detection of EGFR gene mutation in lung cancer by mutant-enriched polymerase chain reaction assay.
    Asano H, Toyooka S, Tokumo M, Ichimura K, Aoe K, Ito S, Tsukuda K, Ouchida M, Aoe M, Katayama H, Hiraki A, Sugi K, Kiura K, Date H, Shimizu N.
    Clin Cancer Res; 2006 Jan 01; 12(1):43-8. PubMed ID: 16397022
    [Abstract] [Full Text] [Related]

  • 15. p53 mutations in lung tumors: relationship to putative susceptibility markers for cancer.
    Ryberg D, Kure E, Lystad S, Skaug V, Stangeland L, Mercy I, Børresen AL, Haugen A.
    Cancer Res; 1994 Mar 15; 54(6):1551-5. PubMed ID: 8137262
    [Abstract] [Full Text] [Related]

  • 16. Quantitative detection of mutant alleles of the K-ras gene with minor groove binder-conjugated fluorogenic DNA probes.
    Itabashi T, Maesawa C, Uchiyama M, Higuchi T, Masuda T.
    Int J Oncol; 2004 Mar 15; 24(3):687-96. PubMed ID: 14767554
    [Abstract] [Full Text] [Related]

  • 17. High incidence of N and K-Ras activating mutations in multiple myeloma and primary plasma cell leukemia at diagnosis.
    Bezieau S, Devilder MC, Avet-Loiseau H, Mellerin MP, Puthier D, Pennarun E, Rapp MJ, Harousseau JL, Moisan JP, Bataille R.
    Hum Mutat; 2001 Sep 15; 18(3):212-24. PubMed ID: 11524732
    [Abstract] [Full Text] [Related]

  • 18. Allele-specific enrichment: a method for the detection of low level N-ras gene mutations in acute myeloid leukemia.
    Todd AV, Ireland CM, Iland HJ.
    Leukemia; 1991 Feb 15; 5(2):160-1. PubMed ID: 2020198
    [Abstract] [Full Text] [Related]

  • 19. ras gene activation in a minor proportion of the blast population in acute myeloid leukemia.
    Toksoz D, Farr CJ, Marshall CJ.
    Oncogene; 1987 Feb 15; 1(4):409-13. PubMed ID: 3330783
    [Abstract] [Full Text] [Related]

  • 20. Designed diagnostic restriction fragment length polymorphisms for the detection of point mutations in ras oncogenes.
    Kumar R, Dunn LL.
    Oncogene Res; 1989 Feb 15; 4(3):235-41. PubMed ID: 2567980
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.